Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

Clinical trial NCT05626712 · RECRUITING

Trial details

NCT number: NCT05626712
Sponsor: Creative Medical Technology Holdings Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Diabetes Mellitus, Type 1

Start date: 2023-04-07
Primary completion: 2027-01-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.